Collonges sous Salève, France

Nathalie Corvaia

USPTO Granted Patents = 15 


 

Average Co-Inventor Count = 3.6

ph-index = 6

Forward Citations = 108(Granted Patents)


Location History:

  • Saint Julien en Genevois, FR (2006 - 2007)
  • St Julien en Genevois, FR (2007)
  • St. Julien En Genevois, FR (2009)
  • Collonges sous Salève, FR (2010 - 2013)
  • Collonges sous Saleve, FR (2011 - 2013)
  • Archamps, FR (2009 - 2014)
  • Collonges Sous Saleves, FR (2015)

Company Filing History:


Years Active: 2006-2015

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Journey of Nathalie Corvaia: Pioneering Advances in Cancer Treatment

Introduction: Nathalie Corvaia, an accomplished inventor based in Collonges sous Salève, France, has made significant strides in biotechnology, particularly focusing on cancer treatment through her innovative antibody research. With a remarkable portfolio of 15 patents, she is at the forefront of developing novel therapeutics that target specific receptors implicated in cancer.

Latest Patents: Among her notable inventions are two patents related to anti-IGF-IR antibodies and their applications. The first patent presents innovative antibodies that specifically bind to the human insulin-like growth factor I receptor (IGF-IR). These antibodies have potential applications as medicinal treatments for cancers that overexpress IGF-IR, driven by IGF1 and IGF2. Furthermore, the invention outlines diagnostic processes or kits that can identify illnesses associated with IGF-IR overexpression and the IGF-I/Insulin hybrid receptor. The second patent details methods for identifying modulators of IGF-IR and hybrid receptors using humanized antibodies, further enhancing therapeutic strategies in oncology.

Career Highlights: Nathalie Corvaia's career is marked by her contributions to renowned companies such as Pierre Fabre Médicament and Merck Sharp & Dohme Corporation. Her work has not only advanced scientific understanding but also propelled innovation in the pharmaceutical industry.

Collaborations: Throughout her career, Corvaia has collaborated with esteemed colleagues like Liliane Goetsch and Alain Beck, fostering teamwork that enhances research outcomes and patent development.

Conclusion: Nathalie Corvaia's journey as an inventor showcases her dedication to advancing cancer treatments through innovative research. With her extensive patent portfolio and collaborative efforts, she continues to make significant contributions to the field of biotechnology, paving the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…